Free Trial

Elevance Health (ELV) Earnings Date, Estimates & Call Transcripts

Elevance Health logo
$420.82 +7.17 (+1.73%)
As of 03:59 PM Eastern

Elevance Health Earnings Summary

Upcoming Q2
Earnings Date
Jul. 16Before Market OpensEstimated
Consensus EPS
(Apr. 22)
$10.60
Actual EPS
(Apr. 22)
$11.97 Beat By $1.37
Actual Revenue
(Apr. 22)
$48.77B

Elevance Health announced Q1 2025 earnings on April 22, 2025, reporting an EPS of $11.97, which beat analysts' consensus estimates of $10.60 by $1.37. Quarterly revenue was reported to be $48.77 billion, above analyst estimates of $46.26 billion. With a trailing EPS of $25.63 and a P/E Ratio of 16.43, Elevance Health's earnings are expected to grow 14.99% next year, from $33.96 to $39.05 per share.

Q1 2025 Earnings Resources

ELV Upcoming Earnings

Elevance Health's next earnings date is estimated for Wednesday, July 16, 2025, based on past reporting schedules.

Get Elevance Health Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Elevance Health and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

ELV Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ELV Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Elevance Health Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20252$10.40$11.57$10.9911.970 - 11.970
Q2 20253$9.85$11.43$10.42 
Q3 20252$8.39$8.59$8.49 
Q4 20253$4.03$7.83$5.72 
FY 202510$32.67$39.42$35.62 
Q1 20262$11.96$12.79$12.38 
Q2 20262$11.33$11.52$11.43 
Q3 20262$9.68$9.87$9.78 
Q4 20262$5.03$6.10$5.57 
FY 20268$38.00$40.28 $39.14

Elevance Health Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
7/16/2025
(Estimated)
--------
4/22/2025Q1 2025$10.60$11.97+$1.37$9.61$46.26B$48.77B
1/23/2025Q4 2024$3.80$3.84+$0.04$1.81$44.63B-
10/17/2024Q3 2024$9.66$8.37 -$1.29$12.38$43.47B$44.72B
7/17/2024Q2 2024$9.99$10.12+$0.13$10.39$42.99B$43.22B
4/18/2024Q1 2024$10.54$10.64+$0.10$11.69$42.49B$42.27B
1/24/2024Q4 2023$5.60$5.62+$0.02$7.61$42.19B$42.45B
10/18/2023Q3 2023$8.45$8.99+$0.54$12.53$42.69B$42.48B
7/19/2023Q2 2023$8.78$9.04+$0.26$10.29$41.64B$43.38B

Elevance Health Earnings - Frequently Asked Questions

Elevance Health has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, July 16th, 2025 based off last year's report dates. Learn more on ELV's earnings history.

Elevance Health updated its first quarter 2025 earnings guidance on Monday, April, 21st. The company provided EPS guidance of 11.970-11.970 for the period, compared to the consensus EPS estimate of 11.480. The company issued revenue guidance of -.

In the previous quarter, Elevance Health (NYSE:ELV) reported $11.97 earnings per share (EPS) to beat the analysts' consensus estimate of $10.60 by $1.37. Learn more on analysts' earnings estimate vs. ELV's actual earnings.

The conference call for Elevance Health's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Elevance Health's latest earnings report can be read online.
Read Transcript

Elevance Health's earnings report can be found in their filing with the SEC.
View SEC filing

Elevance Health (NYSE:ELV) has a recorded annual revenue of $183.12 billion.

Elevance Health (NYSE:ELV) has a recorded net income of $5.98 billion. ELV has generated $25.63 earnings per share over the last four quarters.

Elevance Health (NYSE:ELV) has a trailing price-to-earnings ratio of 16.43 and a forward price-to-earnings ratio of 12.39. The price/earnings-to-growth ratio is 1.18.

Elevance Health's earnings are expected to grow from $33.96 per share to $39.05 per share in the next year, which is a 14.99% increase.

More Earnings Resources from MarketBeat



This page (NYSE:ELV) was last updated on 4/30/2025 by MarketBeat.com Staff
From Our Partners